Results 151 to 160 of about 191,162 (262)

Artificial Intelligence‐Driven Precision Bisphosphonate Therapy in Osteoporosis: Mechanisms, Clinical Applications, Risks, and Future Directions

Orthopaedic Surgery, Volume 18, Issue 11, Page 2309-2319, November 2026.
This comprehensive review integrates 17 benchmark studies to illustrate the transition of osteoporosis management toward precision medicine. The schematic highlights three key clinical applications: AI‐driven opportunistic screening from routine CTs, precision pharmacotherapy selection, and the predictive prevention of adverse events like MRONJ ...
Xiang Yao, Yicong Chao, Xiao Gu, Jingtao Peng, Jishan Yuan, Wei Shi, Fuguo Zhang, Qiwen Bao   +7 more
wiley   +1 more source

Two Years of Alendronate and Calcitonin Treatments for Osteoporosis in Postmenopausal Women - Original Investigation

, 2006
This study was to compare and research the effects of alendronate and calcitonin treatments with 2 years duration in women with postmenopausal osteoporosis.
Gülnur Taşçı Bozbaş, Engin Taştaban, Ömer Faruk Şendur, Gülcan Gürer   +3 more
core  

Higher Bone Mineral Density in Obesity Masks Impaired Bone Remodeling and Disproportionate Musculoskeletal Adaptation in Young Women

The FASEB Journal, Volume 40, Issue 20, 31 October 2026.
Women with obesity exhibited higher total and site‐specific BMD and greater lean mass than lean controls. However, reduced BMD‐to‐fat and lean‐to‐fat mass ratios, increased CTX1 and RANK‐L/OPG, and decreased P1NP and osteocalcin indicated impaired bone remodeling, suggesting that increased BMD masks altered bone turnover and compromised skeletal health.
Yasmin Silva Forte, Caio Andrade‐Santos, Camila Pantoja‐Marinho, Luísa González‐Joaquim, Aline Penna‐De‐Carvalho, Paulo Roberto Falcão Leal, Karynne Grutter Lopes, Luiz Guilherme Kraemer‐Aguiar, Christina Barja‐Fidalgo   +8 more
wiley   +1 more source

Construction and validation of a nomogram for the diagnosis of postmenopausal osteoporosis. [PDF]

Mol Med Rep
Huang LY, Chen Y, Song LR, Zhong ZL, Ali K, Li HM, Hu QF, Hu HH.   +7 more
europepmc   +1 more source

Comparison of Different Treatment Protocols in Osteoporosis

, 2003
The aim of this study was to compare the effectiveness of different medical treatment protocols in osteoporosis. For this purpose 153 postmenopausal women who were diagnosed as osteoporosis were randomly divided into 4 groups and given different medical ...
Ali Aydeniz, Mustafa Güler, Ömer Faruk Şendur   +2 more
core  

Hormonal remodeling and molecular mechanisms in postmenopausal osteoporosis: Pathogenesis and therapeutic implications (Review). [PDF]

Int J Mol Med
Liu W, Li Z, Wang P, Zeng J, Zeng H, Xie Y, Yang R, Yang L, Lin S, Zhang C.   +9 more
europepmc   +1 more source

The Effect of Alendronate and Calcitonin Treatments on Bone Mineral Density and Quality of Life in Women With Postmenopausal Osteoporosis

, 2002
The aim of this study was to compare the effect of alendronate and calcitonin treatments on bone mineral density (BMD) and quality of life of women with postmenopausal osteoporosis.
İ. Dalkıran, F. Taşçıoğlu, C. Öner, E. Sırmagül, O. Armağan   +4 more
core  

Gut Microbiota and SCFA Changes After Alendronate-Calcitriol Therapy in Postmenopausal Osteoporosis. [PDF]

Int J Womens Health
Shen F, Hu L, Xin C, Du F, Zhang S.
europepmc   +1 more source

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation

, 2009
Aim: Comparison of the effectiveness of strontium ranelate (SR) and alendronate sodium (AS) on bone mineral density (BMD) in postmenopausal osteoporosis. Material and Methods: A total of 41 patients were included in the study. 2 gr/day SR was applied a
Sibel Ünsal Delialioğlu, Sumru Özel, Eda Kurt, Sezen Özgönül, Kurtuluş Kaya, Canan Çulha   +5 more
core  

Xylosyltransferase-I serum activity is a promising biomarker for postmenopausal osteoporosis. [PDF]

Sci Rep
Witt A, De Martinis M, Kühle M, Schmidt V, Aitella E, Knabbe C, Faust-Hinse I.   +6 more
europepmc   +1 more source